Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Auteurs » - entrée « Peter Jenner »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Peter J. Whitehouse < Peter Jenner < Peter K. Panegyres  Facettes :

List of bibliographic references indexed by Peter Jenner

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000284 (2011) Maria Papathanou [Suède] ; Sarah Rose [Royaume-Uni] ; Andrew Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni]Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6‐OHDA‐lesioned rats
000318 (2011) Peter Jenner [Royaume-Uni] ; J. William Langston [États-Unis]Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
000324 (2011) Anthony H. Schapira [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Etiology and pathogenesis of Parkinson's disease
000582 (2010) Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets
000603 (2010) Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Andrew Christopher Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni]Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP‐treated common marmosets
000C98 (2008) Peter Jenner [Royaume-Uni]Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities
000D45 (2008) Peter Jenner [Royaume-Uni]Molecular mechanisms of L-DOPA-induced dyskinesia
000D96 (2008) Peter Jenner [Royaume-Uni]Functional models of Parkinson's disease: A valuable tool in the development of novel therapies
001250 (2006) Anthony H. V. Schapira [Royaume-Uni] ; Erwan Bezard [France] ; Jonathan Brotchie [Canada] ; Frdric Calon [Canada] ; Graham L. Collingridge [Royaume-Uni] ; Borris Ferger [Allemagne] ; Bastian Hengerer [Allemagne] ; Etienne Hirsch [France] ; Peter Jenner [Royaume-Uni] ; Nicolas Le Novre [Royaume-Uni] ; Jos A. Obeso [Espagne] ; Michael A. Schwarzschild [États-Unis] ; Umberto Spampinato [France] ; Giora Davidai [États-Unis]Novel pharmacological targets for the treatment of Parkinson's disease
001392 (2005) Mahmoud M. Iravani [Royaume-Uni] ; Sergio Costa [Royaume-Uni] ; Ghassan Al-Bargouthy [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Bai-Yun Zeng [Royaume-Uni] ; Mikko Kuoppam Ki [Royaume-Uni] ; Jose A. Obeso [Espagne] ; Peter Jenner [Royaume-Uni]Unilateral pallidotomy in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets exhibiting levodopa‐induced dyskinesia
001406 (2005) Mahmoud M. Iravani [Royaume-Uni] ; Clement C. M. Leung [Royaume-Uni] ; Mona Sadeghian [Royaume-Uni] ; Claire O. Haddon [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation
001462 (2005) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni]Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates
001478 (2005) Joanna Iczkiewicz [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat
001545 (2005) Mahmoud M. Iravani [Royaume-Uni] ; Emilie Syed [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Louisa C. Johnston [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets
001613 (2004) C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]Levodopa in the treatment of Parkinson's disease: Current controversies
001733 (2003) Peter Jenner [Royaume-Uni]Oxidative stress in Parkinson's disease
001778 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure
001942 (2002) Kevin St P. Mcnaught [États-Unis] ; P. Shashidharan [États-Unis] ; Daniel P. Perl [États-Unis] ; Peter Jenner [Royaume-Uni] ; C. Warren Olanow [États-Unis]Aggresome‐related biogenesis of Lewy bodies
001968 (2001) Michael J. Hurley [Royaume-Uni, États-Unis] ; Deborah C. Mash [États-Unis] ; Peter Jenner [Royaume-Uni]Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson’s disease
001F05 (1998) C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] ; David Brooks [Royaume-Uni]Dopamine agonists and neuroprotection in parkinson's disease
002457 (1994) Jeswinder Sian ; David T. Dexter ; Andrew Lees (neurologue) [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Yves Agid [France] ; France Javoy-Agid [France] ; Peter Jenner ; C. David Marsden [Royaume-Uni]Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

List of associated KwdEn.i

Nombre de
documents
Descripteur
9Parkinson's disease
7dyskinesia
6MPTP
4levodopa
3L‐dopa
3continuous dopaminergic stimulation
3primates
3substantia nigra
2dopamine agonists
2entacapone
2inflammation
2mitochondria
2striatum
11‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
11‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated primates
1L‐Dopa
1Parkinson’s disease
1abnormal involuntary movements
1centrosome
1common marmosets
1environment
1etiology
1genetics
1glial cells
1globus pallidus
1inducible nitric oxide synthase (iNOS)
1motor complications
1motor disability
1neuroprotection
1neurotoxicity
1osteopontin
1oxidative stress
1pallidotomy
1pardoprunox (SLV308)
1partial agonist
1partial lesion
1pathogenesis
1pramipexole
1primate
1proteasome
1rasagiline
1reactive gliosis
1α‐synuclein
1γ‐tubulin

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Peter Jenner" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Peter Jenner" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Peter Jenner
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024